Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 32

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Buffering of cytosolic calcium plays a neuroprotective role by preserving the autophagy-lysosome pathway during MPP+-induced neuronal death

Jung, Shinae, Chung, Yuhyun, Lee, Yunsoo, Lee, Yangsin, Cho, Jin Won, Shin, Eun-Joo, Kim, Hyoung-Chun, Oh, Young J. · 2019 · Cell Death Discovery

Abstract

Parkinson’s disease (PD) is a chronic neurodegenerative disease with no cure. Calbindin, a Ca 2+-buffering protein, has been suggested to have a neuroprotective effect in the brain tissues of PD patients and in experimental models of PD. However, the underlying mechanisms remain elusive. Here, we report that in 1-methyl-4-phenylpyridinium (MPP+)-induced culture models of PD, the buffering of cytosolic Ca 2+ by calbindin-D28 overexpression or treatment with a chemical Ca 2+ chelator reversed impaired autophagic flux, protecting cells against MPP+-mediated neurotoxicity. When cytosolic Ca 2+ overload caused by MPP+ was ameliorated, the MPP+-induced accumulation of autophagosomes decreased and the autophagic flux significantly increased. In addition, the accumulation of damaged mitochondria and p62-positive ubiquitinated protein aggregates, following MPP+ intoxication, was alleviated by cytosolic Ca 2+ buffering. We showed that MPP+ treatment suppressed autophagic degradation via raising the lysosomal pH and therefore reducing cytosolic Ca 2+ elevation restored the lysosomal pH acidity and normal autophagic flux. These results support the notion that functional lysosomes are required for Ca 2+-mediated cell protection against MPP+-mediated neurotoxicity. Thus, our data suggest a novel process in which the modulation of Ca 2+ confers neuroprotection via the autophagy-lysosome pathway. This may have implications for the pathogenesis and future therapeutic targets of PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41420-019-0210-6

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 59

  1. Jankovic, J. Parkinson’s disease: clinical features and diagnosis. J. Neurol., Neurosurg., Psychiatry 79, 368–376 (2008). · DOI · Paper page
  2. Dauer, W. & Przedborski, S. Parkinson’s disease: mechanisms and models. Neuron 39, 889–909 (2003). · DOI · Paper page
  3. Olanow, C. W. The pathogenesis of cell death in Parkinson’s disease–2007. Mov. Disord.: Off. J. Mov. Disord. Soc. 22(Suppl 17), S335–S342 (2007). · DOI · Paper page
  4. Corti, O., Lesage, S. & Brice, A. What genetics tells us about the causes and mechanisms of Parkinson’s disease. Physiol. Rev. 91, 1161–1218 (2011). · DOI · Paper page
  5. Michel, P. P., Hirsch, E. C. & Hunot, S. Understanding dopaminergic cell death pathways in Parkinson disease. Neuron 90, 675–691 (2016). · DOI · Paper page
  6. Erekat, N. S. Apoptosis and its Role in Parkinson’s Disease, in Parkinson’s Disease: Pathogenesis and Clinical Aspects. (eds. T. B. Stoker & J. C. Greenland) (Codon Publications Copyright: The Authors., Brisbane, 2018). · DOI
  7. Venderova, K. & Park, D. S. Programmed cell death in Parkinson’s disease. Cold Spring Harb. Perspect. Med. 2, a009365 (2012). · DOI · Paper page
  8. Karabiyik, C., Lee, M. J. & Rubinsztein, D. C. Autophagy impairment in Parkinson’s disease. Essays Biochem. 61, 711–720 (2017). · DOI
  9. Moors, T. E. et al. Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease. Mol. Neurodegener. 12, 11 (2017). · DOI · Paper page
  10. Xilouri, M., Brekk, O. R. & Stefanis, L. Autophagy and alpha-synuclein: relevance to Parkinson’s disease and related synucleopathies. Mov. Disord.: Off. J. Mov. Disord. Soc. 31, 178–192 (2016). · DOI · Paper page
  11. Wong, E. & Cuervo, A. M. Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 13, 805–811 (2010). · DOI · Paper page
  12. Nixon, R. A. The role of autophagy in neurodegenerative disease. Nat. Med. 19, 983–997 (2013). · DOI · Paper page
  13. Sanchez-Perez, A. M., Claramonte-Clausell, B., Sanchez-Andres, J. V. & Herrero, M. T. Parkinson’s disease and autophagy. Park.’s. Dis. 2012, 429524 (2012).
  14. Hara, T. et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885–889 (2006). · DOI · Paper page
  15. Komatsu, M. et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880–884 (2006). · DOI · Paper page
  16. Yang, Z. & Klionsky, D. J. Eaten alive: a history of macroautophagy. Nat. Cell Biol. 12, 814–822 (2010). · DOI · Paper page
  17. Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T. & Sulzer, D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Sci. (New Y., N. Y.) 305, 1292–1295 (2004). · DOI · Paper page
  18. Han, B. S. et al. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. J. Neurosci.: Off. J. Soc. Neurosci. 23, 5069–5078 (2003). · DOI
  19. Choi, W. S. et al. Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. J. Biol. Chem. 279, 20451–20460 (2004). · DOI · Paper page
  20. Choi, W. S. et al. Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP + -induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J. Neurosci. Res. 57, 86–94 (1999). · DOI · Paper page
  21. Lim, J. et al. Binding preference of p62 towards LC3-ll during dopaminergic neurotoxin-induced impairment of autophagic flux. Autophagy 7, 51–60 (2011). · DOI · Paper page
  22. Lim, J. et al. Nigericin-induced impairment of autophagic flux in neuronal cells is inhibited by overexpression of Bak. J. Biol. Chem. 287, 23271–23282 (2012). · DOI
  23. Choi, H. K., Won, L., Roback, J. D., Wainer, B. H. & Heller, A. Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions. Proc. Natl Acad. Sci. USA 89, 8943–8947 (1992). · DOI
  24. Choi, H. K. et al. Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res. 552, 67–76 (1991). · DOI · Paper page
  25. Yuan, H. H., Chen, R. J., Zhu, Y. H., Peng, C. L. & Zhu, X. R. The neuroprotective effect of overexpression of calbindin-D(28k) in an animal model of Parkinson’s disease. Mol. Neurobiol. 47, 117–122 (2013). · DOI
  26. McMahon, A. et al. Calbindin-D28k buffers intracellular calcium and promotes resistance to degeneration in PC12 cells. Brain Res. Mol. Brain Res. 54, 56–63 (1998). · DOI
  27. Choi, W. S., Lee, E., Lim, J. & Oh, Y. J. Calbindin-D28K prevents drug-induced dopaminergic neuronal death by inhibiting caspase and calpain activity. Biochem. Biophys. Res. Commun. 371, 127–131 (2008). · doi:10.1016/j.bbrc.2008.04.020
  28. Lonskaya, I., Hebron, M. L., Algarzae, N. K., Desforges, N. & Moussa, C. E. Decreased parkin solubility is associated with impairment of autophagy in the nigrostriatum of sporadic Parkinson’s disease. Neuroscience 232, 90–105 (2013). · DOI
  29. Anglade, P. et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson’s disease. Histol. Histopathol. 12, 25–31 (1997).
  30. Katsuragi, Y., Ichimura, Y. & Komatsu, M. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS J. 282, 4672–4678 (2015). · DOI · Paper page
  31. Nakamura, S. & Yoshimori, T. New insights into autophagosome-lysosome fusion. J. Cell Sci. 130, 1209–1216 (2017). · DOI · Paper page
  32. Kimura, S., Noda, T. & Yoshimori, T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3, 452–460 (2007). · DOI · Paper page
  33. Bezprozvanny, I. Calcium signaling and neurodegenerative diseases. Trends Mol. Med. 15, 89–100 (2009). · DOI · Paper page
  34. Fairless, R., Williams, S. K. & Diem, R. Dysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration. Cell Tissue Res. 357, 455–462 (2014). · DOI
  35. Pchitskaya, E., Popugaeva, E. & Bezprozvanny, I. Calcium signaling and molecular mechanisms underlying neurodegenerative diseases. Cell Calcium 70, 87–94 (2018). · DOI · Paper page
  36. Schapira, A. H., Olanow, C. W., Greenamyre, J. T. & Bezard, E. Slowing of neurodegeneration in Parkinson’s disease and Huntington’s disease: future therapeutic perspectives. Lancet (Lond., Engl.) 384, 545–555 (2014). · DOI · Paper page
  37. Swart, T. & Hurley, M. J. Calcium channel antagonists as disease-modifying therapy for Parkinson’s disease: therapeutic rationale and current status. CNS Drugs 30, 1127–1135 (2016). · DOI
  38. Surmeier, D. J., Halliday, G. M. & Simuni, T. Calcium, mitochondrial dysfunction and slowing the progression of Parkinson’s disease. Exp. Neurol. 298, 202–209 (2017). · DOI
  39. Cali, T., Ottolini, D. & Brini, M. Calcium signaling in Parkinson’s disease. Cell Tissue Res. 357, 439–454 (2014). · DOI
  40. Yamada, T., McGeer, P. L., Baimbridge, K. G. & McGeer, E. G. Relative sparing in Parkinson’s disease of substantia nigra dopamine neurons containing calbindin-D28K. Brain Res. 526, 303–307 (1990). · DOI · Paper page
  41. Damier, P., Hirsch, E. C., Agid, Y. & Graybiel, A. M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain: A J. Neurol. 122(Pt 8), 1437–1448 (1999). · DOI · Paper page
  42. Lavoie, B. & Parent, A. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys. Neuroreport 2, 601–604 (1991). · DOI · Paper page
  43. Iacopino, A., Christakos, S., German, D., Sonsalla, P. K. & Altar, C. A. Calbindin-D28K-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity. Brain Res. Mol. Brain Res. 13, 251–261 (1992). · DOI · Paper page
  44. German, D. C., Manaye, K. F., Sonsalla, P. K. & Brooks, B. A. Midbrain dopaminergic cell loss in Parkinson’s disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Ann. New Y. Acad. Sci. 648, 42–62 (1992). · DOI · Paper page
  45. Furukawa, K. et al. Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells. J. Neurochem. 97, 1071–1077 (2006). · DOI
  46. Follett, J., Darlow, B., Wong, M. B., Goodwin, J. & Pountney, D. L. Potassium depolarization and raised calcium induces alpha-synuclein aggregates. Neurotox. Res. 23, 378–392 (2013). · DOI
  47. Choi, W. S. et al. Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2. J. Neurochem. 77, 1531–1541 (2001). · DOI
  48. Oh, Y. J., Wong, S. C., Moffat, M. & O’Malley, K. L. Overexpression of Bcl-2 attenuates MPP + , but not 6-ODHA, induced cell death in a dopaminergic neuronal cell line. Neurobiol. Dis. 2, 157–167 (1995). · DOI
  49. Hwang, J. Y. et al. Proteolytic degradation and potential role of onconeural protein cdr2 in neurodegeneration. Cell Death Dis. 7, e2240 (2016). · DOI
  50. Kim, C. et al. Gel-based protease proteomics for identifying the novel calpain substrates in dopaminergic neuronal cell. J. Biol. Chem. 288, 36717–36732 (2013). · DOI
  51. Han, B. S., Noh, J. S., Gwag, B. J. & Oh, Y. J. A distinct death mechanism is induced by 1-methyl-4-phenylpyridinium or by 6-hydroxydopamine in cultured rat cortical neurons: degradation and dephosphorylation of tau. Neurosci. Lett. 341, 99–102 (2003). · DOI
  52. Decuypere, J. P., Bultynck, G. & Parys, J. B. A dual role for Ca(2+) in autophagy regulation. Cell Calcium 50, 242–250 (2011). · DOI · Paper page
  53. Criollo, A. et al. Regulation of autophagy by the inositol trisphosphate receptor. Cell Death Differ. 14, 1029–1039 (2007). · DOI · Paper page
  54. Khan, M. T. & Joseph, S. K. Role of inositol trisphosphate receptors in autophagy in DT40 cells. J. Biol. Chem. 285, 16912–16920 (2010). · DOI
  55. Medina, D. L. et al. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat. Cell Biol. 17, 288–299 (2015). · DOI · Paper page
  56. Pena-Llopis, S. et al. Regulation of TFEB and V-ATPases by mTORC1. EMBO J. 30, 3242–3258 (2011). · DOI · Paper page
  57. Surmeier, D. J. Calcium, ageing, and neuronal vulnerability in Parkinson’s disease. Lancet Neurol. 6, 933–938 (2007). · DOI · Paper page
  58. Kim, C., Lee, J., Ko, Y. U. & Oh, Y. J. Cyclin-dependent kinase 5-mediated phosphorylation of CHIP promotes the tAIF-dependent death pathway in rotenone-treated cortical neurons. Neurosci. Lett. 662, 295–301 (2018). · DOI
  59. Galluzzi, L. et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ. 16, 1093–1107 (2009). · DOI · Paper page

Cited by

See all 32

Metadata

Authors
Jung, S., Chung, Y., Lee, Y., Lee, Y., Cho, J. W., Shin, E.-J., Kim, H.-C., & Oh, Y. J.
Venue
Cell Death Discovery
Published
2019-08-19
Volume
5
Issue
1
ISSN
2058-7716
Cited by
32
References
8
Language
en
Licence
Funders
National Research Foundation of Korea (2017M37A1025369)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Buffering of cytosolic calcium plays a neuroprotective role by preserving the autophagy-lysosome pathway during MPP+-induced neuronal death. https://app.cochat.ai/papers/10.1038/s41420-019-0210-6
The paper
Jung, S., Chung, Y., Lee, Y., Lee, Y., Cho, J. W., Shin, E.-J., Kim, H.-C., & Oh, Y. J. (2019). Buffering of cytosolic calcium plays a neuroprotective role by preserving the autophagy-lysosome pathway during MPP+-induced neuronal death. Cell Death Discovery. https://doi.org/10.1038/s41420-019-0210-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.